Spire Healthcare Group (LON:SPI) Price Target Raised to GBX 305 at Barclays

Spire Healthcare Group (LON:SPIFree Report) had its target price raised by Barclays from GBX 300 ($3.72) to GBX 305 ($3.78) in a research note published on Friday, Marketbeat reports. The brokerage currently has an overweight rating on the stock.

Spire Healthcare Group Trading Up 0.2 %

Shares of SPI opened at GBX 222 ($2.75) on Friday. The company has a current ratio of 0.78, a quick ratio of 0.74 and a debt-to-equity ratio of 164.23. Spire Healthcare Group has a 12-month low of GBX 202 ($2.50) and a 12-month high of GBX 252.50 ($3.13). The firm has a 50-day moving average price of GBX 216.62 and a 200 day moving average price of GBX 219.79. The firm has a market capitalization of £897.15 million, a P/E ratio of 11,100.00, a P/E/G ratio of 1.06 and a beta of 1.15.

About Spire Healthcare Group

(Get Free Report)

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.

Further Reading

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.